General procedure for the formylation of anilines: 10-13, 29-33 pg S4
Introduction of a methyl group curbs metabolism of pyrido [3,4-d] Table S2 pg S16
Biochemical and cellular data for two matched pairs of compounds containing H or Me at the 6-position of the pyrido [3,4-d] pyrimidine core. Table S3 pg S17
Biochemical and cellular data for triazole modifications based on 35. Table S4 pg S19
Biochemical and cellular data for amine modifications based on 36.
Table S5 pg S21
Anti-proliferative data in CAL51 cell line (GI50 in nM) for key selected compounds.
Table S6 pg S23
Kinase profiling run at 1 µM for compound 36 (Z'-LYTE activity assay).
Table S7 pg S25
Kinase profiling run at 1 µM for compound 36 (LanthaScreen binding assay). Table S8 pg S25
S3
Kinase profiling run at 1 µM for compound 36 (Adapta activity assay).
Table S9 pg S26
468 kinase profiling run at 1 µM for compound 36 (KinomescanTM) Table S10 pg S26
CYP inhibition results for 36. Table S11 pg S27
hERG inhibition tested at 1 and 10 µM for 36. Table S12 pg S27
CaCo-2 data for compound 36. Table S13 pg S28
X-ray data collection and refinement statistics A solution of aniline (1 eq) in formic acid (3 mL) was heated to 100 °C for 1.5 h. The reaction mixture was concentrated in vacuo. The residue was diluted with aq. sat. NaHCO3
and EtOAc. The aqueous layer was re-extracted with CH2Cl2. The combined organic layers were dried (MgSO4) and concentrated in vacuo. The residue was, where necessary, purified by flash column chromatography (0-10% MeOH in CH2Cl2).
N-(4-(1,3-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl)formamide 10
Using 4-(1,3-dimethyl-1H-pyrazol-4-yl)-2-methoxyaniline S1. 
N-(4-(1,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenyl)formamide 11
Using 4-(1,5-dimethyl-1H-pyrazol-4-yl)-2-methoxyaniline S2. Yield = 89%. LCMS (ESI) Rt 1.90 mins, m/z 246.10 (M+H) -used directly in next step without further characterization.
N-(4-(1,2-dimethyl-1H-imidazol-5-yl)-2-methoxyphenyl)formamide 12
Using 4-(1,2-dimethyl-1H-imidazol-5-yl)-2-methoxyaniline S3. 
N-(2-methoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)formamide 13
Using 2-methoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)aniline S6. and Pd(PPh3)4 (12 mg, 10.04 µmol) in DME/MeOH (2:1, 1.5 ml) was heated to 150 °C for 10 mins under microwave irradiation. The reaction mixture was diluted with EtOAc and water.
The combined organic layers were washed with water and brine, dried (MgSO4) and concentrated in vacuo. The residue was purified by flash column chromatography (0-20% MeOH in EtOAc) to afford the title compound (10 mg, 23% 
4-(1,5-Dimethyl-1H-pyrazol-4-yl)-2-methoxyaniline S2
A suspension of 2-methoxybromoaniline (100 mg, 0.495 mmol), 1,5-dimethyl-4-(4,4,5,5- 
4-(1,2-Dimethyl-1H-imidazol-5-yl)-2-methoxyaniline S3
A suspension of 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (925 mg, 3.71 mmol), 5-bromo-1,2-dimethylimidazole (650 mg, 3.71 mmol), CsF (1.7 g, 11.14 mmol) and Pd(PPh3)4 (86 mg, 0.074 mmol) in DME/MeOH (2:1, 18 mL) was heated to 150 
3-Methoxy-N-methyl-4-nitrobenzamide S4
A suspension of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (1.95 g, 10.14 mmol), 1-hydroxybenzotriazole hydrate (1.55 g, 10.14 mmol), methanamine.HCl (0.55 g, 8.12 mmol) and 3-methoxy-4-nitrobenzoic acid (1.0 g, 5.07 mmol) in CH2Cl2 (21 mL) was stirred for 5 mins at r.t. N,N-Diisopropylethylamine (4.4 mL, 25.4 mmol) was added and the reaction mixture was stirred at r. 
3-(3-Methoxy-4-nitrophenyl)-4-methyl-4H-1,2,4-triazole S5
To a suspension of 3-methoxy-N-methyl-4-nitrobenzamide S4 ( 
2-Methoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)aniline S6
A suspension of 3-(3-methoxy-4-nitrophenyl)-4-methyl-4H-1,2,4-triazole S5 (660 mg, 2.82 mmol) and 10% palladium on charcoal (150 mg, 0.141 mmol) in EtOH (100 ml) was subjected to a hydrogen atmosphere for 18 h. The reaction mixture was filtered through
Celite and concentrated in vacuo to afford the title compound (519 mg, 90% 
3-Ethoxy-4-nitrobenzoic acid S7
3-Fluoro-4-nitrobenzoic acid (7.5 g, 40. Hz, 1H), 4.28 (q, J = 7.0 Hz, 2H), 1.46 (t, J = 7.0 Hz, 3H).
3-Ethoxy-4-nitrobenzohydrazide S8
To a cooled (0 °C) solution of 3-ethoxy-4-nitrobenzoic acid S7 (1.06 g 5.02 mmol) and triethylamine (0.86 mL, 6.1 mmol) in THF (10 mL) was added ethyl chloroformate (0.56 mL, 5.85 mmol) dropwise. The reaction was stirred at 0 °C for 15 mins. Hydrazine hydrate (1.27 mL, 26 mmol) was added in one portion and the reaction stirred at 0 °C for 5 mins and then at r.t. for 1 h. The reaction mixture was concentrated in vacuo and diluted with EtOAc and aq.
sat. NaHCO3. The combined organic layers were washed with brine, dried (MgSO4) and 
5-(3-Ethoxy-4-nitrophenyl)-4-methyl-4H-1,2,4-triazole-3-thiol S9
To a solution of 3-ethoxy-4-nitrobenzohydrazide S8 (1.29 g 5.72 mmol) in THF (26 mL)
was added a solution a methyl isothiocyanate (422 mg 5.78 mmol) in THF (5 mL).
Triethylamine (102 uL, 0.71 mmol) was added and the reaction was stirred at r.t for 22 h. The reaction mixture was concentrated in vacuo and dissolved in 1 M NaOH (85 mL) and the reaction was stirred at 45 °C for 2.5 h. The reaction mixture was filtered through Celite and extracted with Et2O. The aqueous layer was acidified using conc. HCl and extracted with to afford the title compound (710 mg, 47%).
2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)aniline S11
A suspension of 3-(3-ethoxy-4-nitrophenyl)-4-methyl-4H-1,2,4-triazole S10 (748 mg 3.19 mmol) and 10% palladium on charcoal (130 mg, 0.123 mmol) in EtOH (50 mL) was subjected to a hydrogen atmosphere for 18 h. The reaction mixture was filtered through S11 Celite and concentrated in vacuo to afford the title compound (539 mg, 83% 
4-(4,5-Dimethyl-4H-1,2,4-triazol-3-yl)-2-ethoxyaniline S12
To a solution of 4-bromo-2-ethoxyaniline (150 mg, 0.694 mmol) in toluene (2 mL) in a 
2-(5-(3-Methoxy-4-nitrophenyl)-4-methyl-4H-1,2,4-triazol-3-yl)-N,Ndimethylethanamine S16
To a suspension of 3-methoxy-N-methyl-4-nitrobenzamide S4 (114 mg, 0.54 mmol) in dichloroethane (4 mL) was added thionyl chloride (0.20 mL, 2.72 mmol). The mixture was heated at 90 °C for 2 h under microwave irradiation. The reaction mixture was concentrated in vacuo and dried for 1 h. Dichloroethane (6 mL), 3-(dimethylamino)propanehydrazide (107 S13 mg, 0.82 mmol) and acetonitrile (6 mL) were added. 
4-(5-(2-(Dimethylamino)ethyl)-4-methyl-4H-1,2,4-triazol-3-yl)-2-ethoxyaniline S17
A suspension of 2-(5-(3-methoxy-4-nitrophenyl)-4-methyl-4H-1,2,4-triazol-3-yl)-N,Ndimethylethanamine S16 (82 mg, 0.27 mmol) and 10% palladium on charcoal (6 mg) in EtOH (4 mL) was subjected to hydrogen atmosphere at 60 psi for 2 days at r.t. The reaction mixture was filtered through Celite and concentrated in vacuo to afford the title compound Ether was added gradually (total of 2.3 mL). The resulting gum was triturated to give a yellow solid. The solid was centrifuged to consolidate the solid and the supernatent was S14 removed by pipette. The solid was resuspended in 1:10 ethanol:ether (about 3mL) and recovered by centrifugation. Finally the solid was washed with ether (about 3 mL) in the same way. The product was dried in vacuo over NaOH and silica gel for a total of 3 h. By chloride analysis the salt was found to correspond to about 1.8 HCl S15 a Results are in nM unless otherwise stated and are mean (± SD) for n ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run n = 1. "P-MPS1" indicates an electrochemiluminescence Meso Scale Discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. a Results are in nM unless otherwise stated and are mean (± SD) for n ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run n = 1. "P-MPS1" indicates an electrochemiluminescence Meso Scale Discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. a Results are in nM unless otherwise stated and are mean (± SD) for n ≥ 3, or mean values of two independent determinations with individual determinations in parentheses or samples run n = 1. "P-MPS1" indicates an electrochemiluminescence Meso Scale Discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. Cells were plated in 96-well plates at 2,500 per well and were treated for 72 h. The optical S23 density was measured at 570 nm using the Wallac VICTOR2TM 1420 Multilabel Counter (PerkinElmer). 
S29
Figure S1: Fo-Fc electron density omit map contoured at 3σ for the crystal structure of MPS1 bound to compound 36 (BOS172722).
